ARTICLE | Company News
Tivorsan, Muscular Dystrophy Association musculoskeletal news
January 16, 2012 8:00 AM UTC
Tivorsan received $1 million from the association to accelerate preclinical development of TVN-102 to treat Duchenne muscular dystrophy (DMD). In October, Tivorsan and its academic collaborators rece...